InvestSMART

IDT Australia Limited (ASX:IDT)

ALERT: Price-sensitive ASX Announcement for IDT
Current share price for IDT : $0.043 0 (0%)+
Announcement
Release
18 Feb 2026 10:12AM
Price at Release
$0.043
Full Release
download
Summary
IDT Australia Limited's half-year report for the period ended 31 December 2025 indicates a significant reduction in loss, with a 59.5% decrease in the loss before tax to $1.3 million compared to the previous corresponding period. Revenues remained stable at $9.8 million. The company achieved operating cash inflows of $1.6 million, improving its financial position with a cash balance of $1.9 million at the end of the period. The company benefited from returning international and domestic customers leveraging Australia's regulatory standards and cost advantages. Key business verticals like Active Pharmaceutical Ingredient manufacturing and Specialty Orals saw substantial growth, while Advanced Therapies experienced a decline attributed to customer timing. The report reflects IDT's strategic transformation towards increased profitability and operational efficiencies.
Key Points
  • Reduction in loss before tax by 59.5% to $1.3 million.
  • Stable revenue at $9.8 million.
  • Operating cash inflows of $1.6 million.
  • Cash balance of $1.9 million by end of the period.
  • Growth in Active Pharmaceutical Ingredient manufacturing by 191.4% to $3 million.
  • Growth in Specialty Orals by 26% to $2.5 million.
  • Decline in Advanced Therapies revenue to $2.9 million due to customer timing.
  • Increased operational efficiencies and cost-saving initiatives.
  • No dividends declared or paid during the period.
  • Audit review found no disputes or qualifications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.